In this webinar, Dr. Kapil Bharti discussed the use of induced pluripotent stem (iPS) cell technology to develop in vitro disease models to study patient-specific disease processes, to set up high throughput drug screens, and to develop cell-based therapy for retinal degenerative disease.

Topics covered:

  • Characterization of iPSC-derived retinal pigment epithelium (RPE)
  • iPSC-derived RPE for ocular disease modeling
  • iPSC-derived RPE in clinical applications